These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7024018)

  • 1. Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF).
    Heinonen J; Peltola K; Himberg JJ; Suomela H
    Dev Biol Stand; 1980; 48():129-30. PubMed ID: 7024018
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction.
    Alving BM; Hojima Y; Pisano JJ; Mason BL; Buckingham RE; Mozen MM; Finlayson JS
    N Engl J Med; 1978 Jul; 299(2):66-70. PubMed ID: 661863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prekallikrein activator levels and side effects with human albumin preparations.
    Lüben G; Quast U; Geiger H
    Dev Biol Stand; 1980; 48():123-7. PubMed ID: 6974110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of hypotensive effect of plasma protein fraction with prekallikrein activator activity: a clinical study in patients having open-heart surgery.
    Heinonen J; Peltola K; Himberg JJ; Suomela H
    Ann Thorac Surg; 1982 Mar; 33(3):244-9. PubMed ID: 6978689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin-mediated hypotension after infusion of plasma-protein fraction.
    Van Rosevelt RF; Bakker JC; Sinclair DM; Damen J; Van Mourik JA
    J Lab Clin Med; 1982 Aug; 100(2):288-95. PubMed ID: 6980251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical hypotension after volume expansion with plasma protein fraction.
    Colman RW
    N Engl J Med; 1978 Jul; 299(2):97-8. PubMed ID: 661869
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia).
    Bakker JC; de Vries-van Rossen A; Radema H; Bleeker W; Ufkes JG; van Rosevelt RF; van Mourik JA
    Adv Exp Med Biol; 1983; 156 (Pt B)():1091-7. PubMed ID: 6602466
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypotensive effects of plasma protein fraction. The relation between prekallikrein activator, bradykinin generation, and blood pressure in an animal model.
    Bleeker WK; Van Rosevelt RF; Ufkes JG; Loos JA; Van Mourik JA; Bakker JC
    J Lab Clin Med; 1982 Oct; 100(4):540-7. PubMed ID: 6981675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-infectious and non-immunologic complications of blood transfusion.
    Snyder EL
    Conn Med; 1979 Apr; 43(4):206-11. PubMed ID: 436416
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardization of prekallikrein activator (PKA): the 1st British reference preparation for PKA.
    Kerry PJ; Curtis AD; Paton CJ; Thomas DP
    Br J Haematol; 1982 Oct; 52(2):275-81. PubMed ID: 6982063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of plasma prekallikrein using beta-XIIa (Hageman factor fragment)].
    Komiyama Y; Egawa H; Murata K
    Rinsho Byori; 1984 May; 32(5):558-62. PubMed ID: 6332927
    [No Abstract]   [Full Text] [Related]  

  • 14. Stable plasma protein solution. Modern preparation methods reduce risk of untoward reactions.
    Schiff P
    Med J Aust; 1982 Jun; 1(12):493. PubMed ID: 6980365
    [No Abstract]   [Full Text] [Related]  

  • 15. Prekallikrein activator in human albumin.
    Paton CJ; Kerry PJ
    Lancet; 1981 Oct; 2(8249):747. PubMed ID: 6116876
    [No Abstract]   [Full Text] [Related]  

  • 16. Prekallikrein activator.
    Gallimore MJ; Friberger P
    Thromb Haemost; 1984 Dec; 52(3):366. PubMed ID: 6335791
    [No Abstract]   [Full Text] [Related]  

  • 17. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin, plasma protein fraction, and hypotension.
    Ellison N; Behar M; MacVaugh H; Marshall BE
    Ann Thorac Surg; 1980 Jan; 29(1):15-9. PubMed ID: 7356802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitor from corn blocks the hypotensive action of plasma protein fraction and active Hageman factor.
    Marks E; Hojima Y; Frech ME; Keiser H; Pisano JJ
    Thromb Res; 1981 Jul 1-15; 23(1-2):97-102. PubMed ID: 6914060
    [No Abstract]   [Full Text] [Related]  

  • 20. Standardization of prekallikrein activator (PKA): the 1st International Standard for PKA.
    Kerry PJ; Curtis AD; Thomas DP
    Br J Haematol; 1985 Jun; 60(2):345-52. PubMed ID: 3873958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.